SEC Form SC 13G/A filed by Pharvaris N.V. (Amendment)

2/14/24 8:42:52 PM ET

$PHVS

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $PHVS alert in real time by email

SC 13G/A 1 tm246235d16_sc13ga.htm SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Pharvaris N.V.

(Name of Issuer)

Ordinary shares, par value €0.12 per share

(Title of Class of Securities)

N69605108

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨	Rule 13d-1(b)

x	Rule 13d-1(c)

¨	Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. N69605108

Page 2 of 14

1.	Names of Reporting Persons Venrock Healthcare Capital Partners III, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only

4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		5.	Sole Voting Power 0
		6.	Shared Voting Power 3,395,606 (2)
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 3,395,606 (2)
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,395,606 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

11.	Percent of Class Represented by Amount in Row (9) 6.5% (3)
12.	Type of Reporting Person (See Instructions) PN

(1)

Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

(2)

(3)

This percentage is calculated based upon 52,108,675 ordinary shares outstanding as of December 8, 2023 as disclosed in the Issuer’s prospectus supplement dated December 6, 2023 filed with the Securities and Exchange Commission on December 7, 2023.

CUSIP No. N69605108

Page 3 of 14

1.	Names of Reporting Persons VHCP Co-Investment Holdings III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only

4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		5.	Sole Voting Power 0
		6.	Shared Voting Power 3,395,606 (2)
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 3,395,606 (2)
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,395,606 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

11.	Percent of Class Represented by Amount in Row (9) 6.5% (3)
12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. N69605108

Page 4 of 14

1.	Names of Reporting Persons Venrock Healthcare Capital Partners EG, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only

4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		5.	Sole Voting Power 0
		6.	Shared Voting Power 3,395,606 (2)
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 3,395,606 (2)
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,395,606 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

11.	Percent of Class Represented by Amount in Row (9) 6.5% (3)
12.	Type of Reporting Person (See Instructions) PN

(1)

(2)

(3)

CUSIP No. N69605108

Page 5 of 14

1.	Names of Reporting Persons VHCP Management III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only

4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		5.	Sole Voting Power 0
		6.	Shared Voting Power 3,395,606 (2)
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 3,395,606 (2)
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,395,606 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

11.	Percent of Class Represented by Amount in Row (9) 6.5% (3)
12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. N69605108

Page 6 of 14

1.	Names of Reporting Persons VHCP Management EG, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only

4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		5.	Sole Voting Power 0
		6.	Shared Voting Power 3,395,606 (2)
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 3,395,606 (2)
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,395,606 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

11.	Percent of Class Represented by Amount in Row (9) 6.5% (3)
12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. N69605108

Page 7 of 14

1.	Names of Reporting Persons Shah, Nimish
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only

4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With		5.	Sole Voting Power 0
		6.	Shared Voting Power 3,395,606 (2)
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 3,395,606 (2)
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,395,606 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

11.	Percent of Class Represented by Amount in Row (9) 6.5% (3)
12.	Type of Reporting Person (See Instructions) IN

(1)

(2)

(3)

CUSIP No. N69605108

Page 8 of 14

1.	Names of Reporting Persons Koh, Bong
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only

4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With		5.	Sole Voting Power 0
		6.	Shared Voting Power 3,395,606 (2)
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 3,395,606 (2)
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,395,606 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

11.	Percent of Class Represented by Amount in Row (9) 6.5% (3)
12.	Type of Reporting Person (See Instructions) IN

(1)

(2)

(3)

CUSIP No. N69605108

Page 9 of 14

Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment III”), Venrock Healthcare Capital Partners EG, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP EG”), VHCP Management III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management III”), VHCP Management EG, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management EG” and collectively with VHCP III LP, VHCP Co-Investment III, VHCP EG and VHCP Management III, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”) in respect of the Ordinary Shares of Pharvaris N.V.

Item 1.

	(a)	Name of Issuer Pharvaris N.V.

	(b)	Address of Issuer’s Principal Executive Offices Emmy Noetherweg 2 2333 BK Leiden The Netherlands

Item 2.

	(a)	Name of Person Filing Venrock Healthcare Capital Partners III, L.P. VHCP Co-Investment Holdings III, LLC Venrock Healthcare Capital Partners EG, L.P. VHCP Management III, LLC VHCP Management EG, LLC Nimish Shah Bong Koh

	(b)	Address of Principal Business Office or, if none, Residence

		New York Office:	Palo Alto Office:

		7 Bryant Park	3340 Hillview Avenue
		23rd Floor	Palo Alto, CA 94304
		New York, NY 10018

	(c)	Citizenship All of the Venrock Entities were organized in Delaware. The individuals are both United States citizens.

	(d)	Title of Class of Securities Ordinary shares, par value €0.12 per share

	(e)	CUSIP Number N69605108

CUSIP No. N69605108

Page 10 of 14

Item 3.	If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	Not applicable

Item 4.	Ownership

	(a)	Amount beneficially owned as of December 31, 2023:

Venrock Healthcare Capital Partners III, L.P.			3,395,606 (1)
VHCP Co-Investment Holdings III, LLC			3,395,606 (1)
Venrock Healthcare Capital Partners EG, L.P.			3,395,606 (1)
VHCP Management III, LLC			3,395,606 (1)
VHCP Management EG, LLC			3,395,606 (1)
Nimish Shah			3,395,606 (1)
Bong Koh			3,395,606 (1)

(b)

Percent of class as of December 31, 2023:

Venrock Healthcare Capital Partners III, L.P.			6.5% (2)
VHCP Co-Investment Holdings III, LLC			6.5% (2)
Venrock Healthcare Capital Partners EG, L.P.			6.5% (2)
VHCP Management III, LLC			6.5% (2)
VHCP Management EG, LLC			6.5% (2)
Nimish Shah			6.5% (2)
Bong Koh			6.5% (2)

(c)	Number of shares as to which the person has, as of December 31, 2023:

	(i)	Sole power to vote or to direct the vote:

Venrock Healthcare Capital Partners III, L.P.			0
VHCP Co-Investment Holdings III, LLC			0
Venrock Healthcare Capital Partners EG, L.P.			0
VHCP Management III, LLC			0
VHCP Management EG, LLC			0
Nimish Shah			0
Bong Koh			0

(ii)

Shared power to vote or to direct the vote:

Venrock Healthcare Capital Partners III, L.P.			3,395,606 (1)
VHCP Co-Investment Holdings III, LLC			3,395,606 (1)
Venrock Healthcare Capital Partners EG, L.P.			3,395,606 (1)
VHCP Management III, LLC			3,395,606 (1)
VHCP Management EG, LLC			3,395,606 (1)
Nimish Shah			3,395,606 (1)
Bong Koh			3,395,606 (1)

CUSIP No. N69605108

Page 11 of 14

(iii)

Sole power to dispose or to direct the disposition of:

Venrock Healthcare Capital Partners III, L.P.			0
VHCP Co-Investment Holdings III, LLC			0
Venrock Healthcare Capital Partners EG, L.P.			0
VHCP Management III, LLC			0
VHCP Management EG, LLC			0
Nimish Shah			0
Bong Koh			0

(iv)

Shared power to dispose or to direct the disposition of:

Venrock Healthcare Capital Partners III, L.P.			3,395,606 (1)
VHCP Co-Investment Holdings III, LLC			3,395,606 (1)
Venrock Healthcare Capital Partners EG, L.P.			3,395,606 (1)
VHCP Management III, LLC			3,395,606 (1)
VHCP Management EG, LLC			3,395,606 (1)
Nimish Shah			3,395,606 (1)
Bong Koh			3,395,606 (1)

(1)

Consists of (i) 564,312 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 56,444 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 2,774,850 shares held by Venrock Healthcare Capital Partners EG, L.P. VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and the manager of VHCP Co-Investment Holdings III, LLC. VHCP Management EG, LLC is the general partner of Venrock Healthcare Capital Partners EG, L.P. Messrs. Shah and Koh are the voting members of VHCP Management III, LLC and VHCP Management EG, LLC.

(2)

Item 5.	Ownership of Five Percent or Less of a Class

	If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨

CUSIP No. N69605108

Page 12 of 14

Item 6.	Ownership of More than Five Percent on Behalf of Another Person

	Not applicable

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

	Not applicable

Item 8.	Identification and Classification of Members of the Group

	Not applicable

Item 9.	Notice of Dissolution of Group

	Not applicable

Item 10.	Certification

	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

CUSIP No. N69605108

Page 13 of 14

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2024

Venrock Healthcare Capital Partners III, L.P.		Venrock Healthcare Capital Partners EG, L.P.

By:	VHCP Management III, LLC	By:	VHCP Management EG, LLC
Its:	General Partner	Its:	General Partner

By:	/s/ Sherman G. Souther	By:	/s/ Sherman G. Souther
	Name: Sherman G. Souther		Name: Sherman G. Souther
	Its: Authorized Signatory		Its: Authorized Signatory

VHCP Co-Investment Holdings III, LLC

By:	VHCP Management III, LLC
Its:	Manager

By:	/s/ Sherman G. Souther
	Name: Sherman G. Souther
	Its: Authorized Signatory

VHCP Management III, LLC		VHCP Management EG, LLC

By:	/s/ Sherman G. Souther	By:	/s/ Sherman G. Souther
	Name: Sherman G. Souther		Name: Sherman G. Souther
	Its: Authorized Signatory		Its: Authorized Signatory

Nimish Shah

/s/ Sherman G. Souther
Sherman G. Souther, Attorney-in-fact

Bong Koh

/s/ Sherman G. Souther
Sherman G. Souther, Attorney-in-fact

CUSIP No. N69605108

Page 14 of 14

EXHIBITS

A:	Joint Filing Agreement (incorporated by reference to Exhibit A to Schedule 13G filed on November 30, 2023)

B:	Power of Attorney for Nimish Shah (incorporated by reference to Exhibit B to Schedule 13G filed November 30, 2023)

C:	Power of Attorney for Bong Koh (incorporated by reference to Exhibit C to Schedule 13G filed on November 30, 2023)

Get the next $PHVS alert in real time by email

Date	Price Target	Rating	Analyst
6/11/2025	$32.00	Buy	Guggenheim
4/29/2025	$28.00	Overweight	Cantor Fitzgerald
9/25/2023	$27.00	Outperform	Wedbush
8/15/2023	$10.00 → $34.00	Equal-Weight → Overweight	Morgan Stanley
10/5/2022	$16.00	Buy	Bryan Garnier
9/13/2022	$34.00 → $18.00	Mkt Outperform	JMP Securities
8/23/2022	$40.00 → $10.00	Overweight → Equal-Weight	Morgan Stanley
8/22/2022	$26.00 → $13.00	Neutral → Underperform	BofA Securities

SEC Form SC 13G/A filed by Pharvaris N.V. (Amendment)

Chat with this insight

Recent Analyst Ratings for
$PHVS

$PHVS
Press Releases

Fastest customizable press release news feed in the world

NodThera Announces Appointment of Elisabeth Björk as Board Member

Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress

Pharvaris Announces Annual Meeting of Shareholders

$PHVS
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Guggenheim initiated coverage on Pharvaris N.V. with a new price target

Cantor Fitzgerald initiated coverage on Pharvaris N.V. with a new price target

Wedbush initiated coverage on Pharvaris N.V. with a new price target

$PHVS
SEC Filings

SEC Form 6-K filed by Pharvaris N.V.

SEC Form 6-K filed by Pharvaris N.V.

SEC Form 6-K filed by Pharvaris N.V.

$PHVS
Financials

Live finance-specific insights

Pharvaris Provides Business Update and Expands Development Program for Deucrictibant

Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks

Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks

$PHVS
Large Ownership Changes

This live feed shows all institutional transactions in real time.